The relationship between dosing of alosetron and discontinuation patterns reported by patients participating in a follow-up programme

Alimentary Pharmacology and Therapeutics

Volumn 25, Issue 3, 2007, Pages 317-322

  Tennis, P ^a   Andrews, E ^a   Hickman, P ^a   Miller, D ^a   Hollis, K ^a   Cook, S ^b  

^a RTI HEALTH SOLUTIONS   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON;

ADULT; AGED; ARTICLE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK MANAGEMENT; TIME SERIES ANALYSIS; TREATMENT PLANNING;

ADULT; AGED; CARBOLINES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PATIENT COMPLIANCE;

EID: 33846312797     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03198.x     Document Type: Article

References (5)

1. Miller DP, Bennett L, Hollis KA, Tennis P, Cook SF, Andrews E. A patient follow-up survey programme for alosetron: assessing compliance to and effectiveness of the risk management programme. Aliment Pharmacol Ther 2006; 24: 869-78.
2. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
3. FDA Advisory Committee Proceedings 2004. Available at: http://www.fda.gov/ohrms/dockets/ac/04/briefing/4040b1.htm.
4. McDonald HP, Garg, AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions. JAMA 2002; 288: 2868-79.
5. Conlin PR, Gerth WC, Fox J, Roehm JB, Boccuzzi SJ. Four-year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other antihypertensive drug classes. Clin Ther 2001; 23: 1999-2010.